tirzepatide approval Eli Lilly's gained FDA in December 2024 for treating moderate-to-severe obstructive sleep apnea in adults with obesity, after Phase III trials showed a 20% average weight loss and a roughly Compounded Tirzepatide - HelloWellness

Clinical trials have shown that gastrointestinal issues are the most frequently reported side effects, with nausea affecting 36.6% of users, followed by diarrhea at 8.6% and fatigue at 6.3% [9]

Ozempic is an injectable prescription drug designed to help with the effects of type 2 diabetes

This reflects the PK-PD disconnect the biological effects triggered by the peptide persist beyond the peptide itself

One is retatrutide, an injectable drug Eli Lilly is developing thats a triple agonist, meaning that in addition to GLP-1 and GIP, it also targets glucagon

Since chronic stress depletes your body of this necessary antioxidant, find ways to manage stress in your life